200 Participants Needed

HD-tDCS + Speech Therapy for Aphasia

SE
SP
Overseen BySara Pillay, Ph.D
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Medical College of Wisconsin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how gentle electrical stimulation (targeted transcranial direct current stimulation), combined with speech therapy, aids in recovering language skills after a stroke. Participants will be divided into groups to receive either real or sham electrical stimulation, along with one of two types of speech therapy. The trial targets individuals who have experienced a stroke or similar event affecting language abilities and can speak English. Participants must be comfortable with MRIs and free from certain health conditions, such as severe mental health issues or advanced neurodegenerative diseases. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance recovery options for stroke survivors.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that transcranial direct-current stimulation (tDCS) combined with speech therapy can aid in regaining language skills after a stroke. Studies have found tDCS to be safe, noninvasive, and painless, causing no harm or discomfort during use.

In earlier studies, both regular and high-definition tDCS (HD-tDCS) were well-received. Participants improved in naming objects and answering questions more quickly, indicating that side effects are minor and the treatment is manageable.

Overall, previous research suggests that using HD-tDCS with speech therapy is safe for individuals with language difficulties after a stroke. This combination may enhance speech recovery without causing significant discomfort or harm.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about this trial because it explores the combination of HD-tDCS and specialized speech therapy to treat aphasia in a novel way. Unlike traditional speech therapy, which focuses solely on language exercises, HD-tDCS (high-definition transcranial direct current stimulation) uses electrical stimulation to potentially enhance brain plasticity and recovery. This dual approach might offer a more effective rehabilitation by directly targeting brain function while simultaneously engaging language skills. The possibility of synergistic effects between the electrical stimulation and targeted speech therapy is what has researchers intrigued about its potential benefits for those with aphasia.

What evidence suggests that this trial's treatments could be effective for aphasia?

Research has shown that high-definition transcranial direct current stimulation (HD-tDCS) combined with speech therapy can aid in recovering language skills after a stroke. In this trial, participants will be randomized to receive either anodal HD-tDCS or sham-tDCS. Studies have found that HD-tDCS, when paired with speech therapy, enables people to name objects more accurately and quickly than speech therapy alone. This gentle electrical stimulation can enhance naming accuracy and response speed.

Another group in this trial will receive speech therapy, which is also highly effective. Real-world evidence indicates that intensive speech therapy can significantly improve language comprehension and speaking skills. Many patients experience positive changes, especially with 20 to 50 hours of therapy. These findings suggest that both HD-tDCS and speech therapy can aid language recovery after a stroke.13678

Are You a Good Fit for This Trial?

This trial is for adults over 18 with aphasia from left-sided brain damage like a stroke, who can speak English and are MRI-eligible. It's not for those with advanced neurodegenerative diseases, unmanaged seizure disorders, severe mental health issues, major hearing or vision problems, developmental disabilities, or MRI contraindications such as metal implants.

Inclusion Criteria

My eligibility is not affected by my race, ethnicity, or gender.
I am an adult who speaks and understands English fluently.
You are able to have an MRI scan.
See 1 more

Exclusion Criteria

I have hearing, vision difficulties, or a learning disability that cannot be corrected.
I cannot have an MRI due to claustrophobia, implants, metal in my body, obesity, pregnancy, or inability to lie flat or see/hear well.
I have a neurological condition like epilepsy, Parkinson's, or ALS.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment Cycle A

Participants receive targeted anodal-tDCS or sham-tDCS along with speech therapy for 10 sessions

2 weeks
10 visits (in-person)

Assessment and Crossover

Participants undergo behavioral assessment and fMRI before crossing over to receive the alternate tDCS intervention

1-2 weeks

Treatment Cycle B

Participants receive the alternate tDCS intervention along with the same speech therapy arm for another 10 sessions

2 weeks
10 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment with behavioral assessments and fMRI at 3 and 6 months post Treatment Cycle B

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Speech Therapy
  • Targeted Transcranial Direct Current Stimulation
Trial Overview The study tests if mild electrical stimulation to the brain (HD-tDCS) combined with speech therapy helps language recovery in people who have speech difficulties after a stroke. Participants will receive this combination treatment and their progress will be monitored.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Speech TherapyExperimental Treatment1 Intervention
Group II: HD-tDCSExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

Published Research Related to This Trial

Transcranial direct current stimulation (tDCS) is a promising non-invasive technique that can enhance the effectiveness of speech therapy for individuals with aphasia, as indicated by a review of 35 studies published over the last decade.
Combining tDCS with online speech therapy interventions is more beneficial than offline methods, suggesting that real-time application of tDCS during therapy can lead to better improvements in language deficits.
[Transcranial direct current stimulation and speech therapy intervention in people with aphasia: a systematic review of the literature].Corrales-Quispiricra, C., Gadea, ME., Espert, R.[2021]
Transcranial direct current stimulation (tDCS) combined with language training showed improved verb production in a 43-year-old male with fluent-anomic aphasia after a stroke, suggesting enhanced language recovery.
The study indicates that using tDCS over Broca's area during language therapy may effectively support brain plasticity and improve language skills in individuals with aphasia.
Translational treatment of aphasia combining neuromodulation and behavioral intervention for lexical retrieval: implications from a single case study.Galletta, EE., Vogel-Eyny, A.[2020]
Transcranial direct current stimulation (tDCS) combined with speech and language treatment (SLT) is safe for stroke survivors with aphasia, showing no serious adverse events during a six-week treatment involving 30 sessions.
Participants receiving active tDCS exhibited greater improvements in functional language compared to those receiving sham treatment, suggesting that tDCS may enhance the effectiveness of SLT, although the superiority of one stimulation polarity over another remains unclear.
Extended fMRI-Guided Anodal and Cathodal Transcranial Direct Current Stimulation Targeting Perilesional Areas in Post-Stroke Aphasia: A Pilot Randomized Clinical Trial.Cherney, LR., Babbitt, EM., Wang, X., et al.[2021]

Citations

Effect of transcranial direct current stimulation combined ...tDCS combined with SLT demonstrates potential enhancement in language recovery on post-ischemic stroke aphasia. The combination may augment speech content, ...
Effectiveness of Transcranial Direct Current Stimulation as ...The weight of the evidence suggests that tDCS paired with SLT improves noun-naming outcomes in chronic aphasia beyond the effects of SLT alone.
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/25547776/
Feasibility of using high-definition transcranial direct ... - PubMedCS-tDCS and HD-tDCS were comparable in terms of implementation, acceptability, and outcomes. Naming accuracy and response time improved for both stimulation ...
Effects of Transcranial Direct Current Stimulation (tDCS) on ...This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance ...
Efficacy of Transcranial Magnetic Stimulation and ...Evidence suggests that rTMS can improve naming, repetition, writing, and comprehension abilities in post-stroke aphasia patients [84,85,86,87,88] ...
Transcranial Direct-Current Stimulation and Behavioral ...tDCS has led to promising results in rehabilitating patients with acquired aphasia, especially if combined with different language and communication therapies.
Feasibility of using high-definition transcranial direct current ...CS-tDCS and HD-tDCS were comparable in terms of implementation, acceptability, and outcomes. Naming accuracy and response time improved for both stimulation ...
Transcranial Direct-Current Stimulation in Subacute AphasiaTranscranial direct-current stimulation (tDCS) is a promising adjunct to traditional language therapy. tDCS is a safe, noninvasive, nonpainful ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity